It has been shown that in pancreatic cancer, gain-of-function (GOF) mutant p53 induce CAFs to secrete heparan sulfate proteoglycan 2 (HSPG2, or perlecan), an ECM proteoglycan. This evidence concerns the gene TP53 and pancreatic neoplasm.